We are live on
!
Find out more
SA
Sicart Associates Portfolio holdings
AUM
$389M
1-Year Est. Return
42.46%
This Fund
S&P 500
This Quarter
Est. Return
+5.42%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$189M
AUM Growth
+$49.6M
(+35%)
Cap. Flow
+$42.6M
Cap. Flow
% of AUM
22.51%
Top 10 Holdings %
Top 10 Hldgs %
43.99%
Holding
100
New
27
Increased
42
Reduced
4
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short High Yield
SJB
|
+$7.78M |
| 2 |
Fortuna Silver Mines
FSM
|
+$3.94M |
| 3 |
APA Corp
APA
|
+$1.44M |
| 4 |
Microsoft
MSFT
|
+$1.23M |
| 5 |
Applied Materials
AMAT
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short S&P500
SH
|
+$370K |
| 2 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$157K |
| 3 |
Clean Energy Fuels
CLNE
|
+$33.6K |
| 4 |
OraSure Technologies
OSUR
|
+$27.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.92% |
| 2 | Technology | 17.95% |
| 3 | Energy | 15.91% |
| 4 | Materials | 8.04% |
| 5 | Industrials | 5.3% |
Similar funds
AIM
WCM
HP
P8IP
PFPGI
PG
S
LHC
Sicart Associates's Q4 2017 Portfolio in Review
As of Q4 2017, Sicart Associates held 100 positions worth $189M, up 35% from $140M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Sicart Associates deployed $42.6M of net new capital in Q4 2017, opening 27 new positions and adding to 42 existing holdings. Its largest new stake was ProShares Short High Yield: 335,480 shares worth $7.76M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was ProShares Short S&P500, an estimated $370K trimmed.
- Sicart Associates's largest Q4 2017 buy was ProShares Short High Yield: 335,480 shares worth $7.76M.
- Sicart Associates added most to APA Corp in Q4 2017, an estimated $1.44M increase.
- Sicart Associates's biggest Q4 2017 reduction was ProShares Short S&P500, cutting an estimated $370K.
- Sicart Associates fully exited SANGAMO THERAPEUTICS INC in Q4 2017, selling an estimated $157K.
- Sicart Associates's ten largest holdings make up 44% of its $189M portfolio in Q4 2017.
- Sicart Associates opened 27 new positions and closed 1 in Q4 2017.
- Sicart Associates's portfolio value rose 35% quarter-over-quarter to $189M.
Based on Sicart Associates's 13F filing for Q4 2017, filed 17 Jan 2018.